Andreas Boldt
Leipzig, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Type-II-CD20-targeted therapy for CD38 antibody-refractory antibody-mediated rejection after kidney transplantation: a case report.
Journal: Frontiers in immunology
Published: April 28, 2026
Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myeloma.
Journal: HemaSphere
Published: September 11, 2025
Atopic Multimorbidity in Adults With a Focus on Sensitization Patterns and T Cell Activation.
Journal: Clinical and translational allergy
Published: May 11, 2025
Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma.
Journal: HemaSphere
Published: February 13, 2025
Effective use of anti-CD19 chimeric antigen receptor T cells in a case of treatment-resistant granulomatosis with polyangiitis.
Journal: Annals of the rheumatic diseases
Published: January 11, 2025
Extracorporeal photopheresis-New insights into an old procedure.
Journal: Transfusion medicine (Oxford, England)
Published: December 14, 2024
Differential Expression of Immune Checkpoints TIM-3, LAG-3, TIGIT, and Siglec-7 on Circulating Natural Killer Cells - Insights from Healthy Donors Compared to Gastric Cancer Patients.
Journal: Oncology research and treatment
Published: September 30, 2024
Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma.
Journal: Blood cancer discovery
Published: May 09, 2024
Last Updated: 09/26/2026